August 20, 2015 |
A Gloucester Township woman who had traveled to West Africa this month to visit relatives remained hospitalized Wednesday with malaria, officials said. For a brief period, until lab tests confirmed she had malaria, the woman - who was being monitored because of her travels - was treated as a patient potentially with the highly contagious Ebola. The 38-year-old woman called authorities Tuesday evening to report she had a high fever, a symptom of both malaria and Ebola, said Claudia Funaro, director of nursing for the Camden County Department of Health and Human Services.
August 2, 2015 |
Every morning, first thing, Mary Moore Kieh searches Craigslist for old EKG and X-ray machines. Maybe one day she'll get lucky and find an operating room light. Kieh, 49, a nurse at Mercy Fitzgerald Hospital in Darby, is building a clinic in her native Liberia. She knows she cannot save the world. But she may save some people who come to her clinic. And maybe they can help others. And perhaps just by trying, she will inspire others to make more of their own lives, to have hope, even a dream.
April 3, 2015 |
Trish Henwood, the University of Pennsylvania emergency-room physician who twice went to Liberia to fight Ebola, says global intervention - albeit too late - still saved hundreds of thousands of lives. She also says the frantic reaction here showed U.S. leaders that improving health systems in fragile African nations is in our national security interest. Henwood, who gave Penn's annual Global Distinguished Lecture on Tuesday evening, told a rapt audience that fear too often trumped science and "definitely hampered the response . . . and led to more panic than preparedness.
January 18, 2015 |
Healthcare giant Johnson & Johnson, which has operations in the Philadelphia region, said it has formed a consortium to boost the drugmaker's efforts to quickly develop an Ebola vaccine, and the European-based Innovative Medicines Initiative (IMI) plans to award $115.8 million (100 million Euros) to help the project. IMI is a public-private initiative whose goal is to speed up the development of better and safer medicines. Besides J&J's Janssen Pharmaceutical division, the consortium includes the London School of Hygiene & Tropical Medicine, University of Oxford, Institut National de la Sante et de la Recherche Medicale (INSERM)
January 4, 2015 |
Google calls it "The Year in Search 2014" - a snapshot of what people went looking for throughout the year. The list used to be called the "Google Zeitgeist," but that name evidently was too self-congratulatory for even this self-congratulatory search-engine giant. Still, it says a little about human beings and what interests them. Just maybe, it says a lot. Remember that, worldwide, the Internet/Web is a minority pursuit. Despite the withering hailstorm of overwrought self-promotion, only about 40 percent of humanity has access.
January 3, 2015 |
Trish Henwood is home from Liberia, where she spent five weeks working in an Ebola treatment unit, but on Monday the University of Pennsylvania emergency department physician is going back. Henwood, 34, director of global initiatives for the emergency department of Penn's health system, called the experience the most profound of her life. She said she declared more people dead - probably 40 - than she ever had or likely ever will in an American emergency room. The dying children ripped her apart the most.
December 4, 2014 |
TWO CITY HOSPITALS have been tapped to help treat Ebola patients who land on American soil. Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania are two of 35 hospitals throughout the country chosen to house Ebola treatment centers, the Centers for Disease Control and Prevention announced yesterday. CHOP and HUP were selected by a panel of local, state and federal officials for inclusion in the program, which bolsters the three national treatment facilities at Emory University Hospital, Nebraska Medical Center and the National Institutes of Health, according to the CDC. "We were among the first in the nation to offer our special expertise in this global crisis, and we welcome the . . . confidence in our abilities," said Susan Phillips, Penn Medicine's senior vice president for public affairs.
December 4, 2014 |
The Hospital of the University of Pennsylvania and Children's Hospital of Philadelphia have been named Ebola treatment centers by state health officials, the Department of Health and Human Services announced Tuesday. The two hospitals are among 35 designated to treat Ebola in 12 states and the District of Columbia, and are the only two in Pennsylvania. Robert Wood Johnson University Hospital in New Brunswick was also identified as a treatment center, the only hospital named in New Jersey.
November 27, 2014 |
Dr. Mel Kohn is at the intersection of the governmental, nonprofit, and corporate efforts directed at the Ebola crisis in West Africa. Kohn, who lives in Philadelphia, works for Merck & Co. in West Point, Montgomery County. He joined Merck Vaccines after 14 years of work in public health for the State of Oregon. With the drugmaker's office of corporate philanthropy funding the trip, he and Merck colleague John Grabenstein visited Sierra Leone in October as part of a group put together by the Virginia-based nonprofit Project HOPE and invited by the Sierra Leone government.
November 26, 2014 |
Itching to compete and join the fight to solve one of the world's most talked-about health concerns, Merck & Co. got back in the business of making Ebola vaccine Monday. The pharmaceutical giant announced that it will pay at least $30 million to license a potential drug from a small, Iowa-based company called NewLink Genetics Corp. NewLink will get a second payment of $20 million once the next phase of clinical trials starts, which might be in the first months of 2015 - a sign of the accelerated process.